Population Pharmacokinetic Modelling for Nifedipine to Evaluate the Effect of Parathyroid Hormone on CYP3A in Patients with Chronic Kidney Disease.
Chengxiao FuQi PeiWu LiangBo YangWei LiJun LiuHongyi TanCheng-Xian GuoHao ZhangGuo-Ping YangPublished in: Drug design, development and therapy (2022)
This study provides insight into the effects of PTH on CYP3A-mediated clearance pathways. Moreover, PTH could be used as a guide for the appropriate administration of CYP3A eliminated drugs in patients with CKD.
Keyphrases